Send the following on WhatsApp
Continue to ChatIASO Bio Publicizes NMPA's IND Acclaim for Equecabtagene Autoleucel in Second-Line Therapy of Just a few Myeloma, Industry Info https://www.tamfitronics.com/news/business-news/iaso-bio-publicizes-nmpas-ind-acclaim-for-equecabtagene-autoleucel-in-second-line-therapy-of-just-a-few-myeloma-industry-info/